Advertisement

Topics

Anjelo Mida, Inc. Company Profile

18:52 EST 15th December 2018 | BioPortfolio

Anjelo Mida, Inc. was established in 1998 as a pharmaceutical distributor providing fast and reliable medical products and services to the world. We have then expanded our line of products to vaccines, injectables, chemotherapy drugs, hospital drugs, and a variety of disposable medical products.We supply to physicians, pharmacies, clinics, university and colleges, and even hospitals. Our prices are very competitive in the U.S.A. with both generic and brand names. We can also offer asian and european pharmaceuticals for "export only" to any foreign individual or company. We specialize in researching "hard to find medicines" from around the world. Anjelo Mida, also provides one of the most complete lines of high quality chemicals for use in research and laboratories today. We will help you save money and time with your purchases of pharmaceuticals, chemicals and medical supplies

Location

4617 Benson Avenue, Suite A
Baltimore
Maryland
21227
United States of America

Contact

Phone: 410-737-8449
Fax: 410-737-8450
Email: info@anjelomida.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Proteobacterial Origin of Protein Arginine Methylation and Regulation of Complex I Assembly by MidA.

The human protein arginine methyltransferase NDUFAF7 controls the assembly of the ∼1-MDa mitochondrial complex I (CI; the NADH ubiquinone oxidoreductase) by methylating its subunit NDUFS2. We determ...

Peridinin Is an Exceptionally Potent and Membrane-Embedded Inhibitor of Bilayer Lipid Peroxidation.

Antilipoperoxidant protein dysfunction is associated with many human diseases, suggesting that bilayer lipid peroxidation may contribute broadly to pathogenesis. Small molecule inhibitors of this memb...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine)

The rationale of MIDA trial is to determine efficacy and tolerability of ranolazine molecule among Pakistan population and obtain firsthand knowledge about the molecule ranolazine.

Companies [1 Associated Companies listed on BioPortfolio]

Anjelo Mida, Inc.

Anjelo Mida, Inc. was established in 1998 as a pharmaceutical distributor providing fast and reliable medical products and services to the world. We have then expanded our line of products to vaccines...

More Information about "Anjelo Mida, Inc." on BioPortfolio

We have published hundreds of Anjelo Mida, Inc. news stories on BioPortfolio along with dozens of Anjelo Mida, Inc. Clinical Trials and PubMed Articles about Anjelo Mida, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Anjelo Mida, Inc. Companies in our database. You can also find out about relevant Anjelo Mida, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...


Corporate Database Quicklinks



Searches Linking to this Company Record